Intuitive Surgical stock (US46120E6023): shares trade lower in 2026 after strong Q1 earnings beat

Nasdaq-listed Intuitive Surgical shares are trading well below their 2026 opening level even after the US medical-technology group reported a solid earnings beat for Q1 2026 and outlined continued growth in its robotic-surgery installed base.

Nasdaq-listed Intuitive Surgical shares have been under pressure in 2026 despite a solid start to the year, with the stock trading around USD 424 per share on Nasdaq as of the latest close cited on 05/29/2026, well below the roughly USD 566 level seen at the start of 2026 according to MarketBeat data as of 05/29/2026.MarketBeat as of 05/29/2026

For investors following the United States-based medical-technology group, the key milestone in the current reporting cycle was the Q1 2026 earnings release on 04/21/2026, where Intuitive Surgical posted earnings per share of USD 2.50 versus a consensus estimate of USD 2.08 and reported quarterly revenue of USD 2.77 billion, as summarized by MarketBeat from the companys filings and conference call materials dated 04/21/2026.MarketBeat earnings overview as of 05/30/2026

The stock traded at USD 424.59 on 05/29/2026 on Nasdaq, reflecting a 12-month price decline of about 22.96 percent and a year-to-date return of approximately -25.03 percent based on the latest price-history data, which still implies a market capitalization near USD 150.4 billion and a one-day volume of around 3.44 million shares according to MarketBeat as of 05/29/2026.MarketBeat price history as of 05/29/2026

As of: 06/01/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Intuitive Surgical
• Sector/industry: Medical technology, robotic-assisted surgery
• Headquarters/country: Sunnyvale, United States
• Core markets: North America, Europe, Asia-Pacific hospitals and surgical centers
• Key revenue drivers: Robotic surgical systems, instruments and accessories, and procedure-linked service contracts
• Home exchange/listing venue: Nasdaq (ISRG)
• Trading currency: USD

Intuitive Surgical: core business model

Intuitive Surgical focuses on designing and commercializing robotic-assisted surgical platforms and related instruments, with revenue primarily tied to system placements, recurring instrument usage, and service agreements linked to procedure volumes across its global hospital customer base.

What banks and research houses say about Intuitive Surgical

Analyst coverage for Intuitive Surgical on Wall Street remains active in 2026, with multiple US and global investment banks publishing views on the companys growth prospects, capital expenditure cycles in hospitals, and the competitive landscape in minimally invasive robotic surgery, although individual target prices and rating changes vary across institutions and are regularly updated following quarterly earnings and company guidance.

According to consensus data compiled by MarketBeat as of late May 2026, Intuitive Surgical is followed by a broad group of sell-side analysts who factor in metrics such as the companys trailing earnings per share of USD 8.25, an expected earnings increase to around USD 8.57 in the current year and USD 9.81 next year, and a trailing price-earnings ratio near 51, underscoring the growth-oriented valuation profile that typically features in research discussions.MarketBeat earnings overview as of 05/30/2026

Conclusion

The current trading level of Intuitive Surgical on Nasdaq, well below the price at the start of 2026, stands in contrast to the companys strong Q1 2026 earnings beat and ongoing revenue growth from its robotic-surgery platforms. Analyst discussions highlighted by consensus data focus on whether expected double-digit earnings expansion and continued procedure growth justify the stocks premium multiple in the United States medical-technology space. For retail investors, the combination of solid operational performance and a marked share-price pullback in 2026 underscores the importance of monitoring upcoming earnings dates, guidance updates, and any shifts in hospital capital spending that could influence demand for Intuitive Surgical systems over the coming quarters.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.